Crossmark

Continuing evaluation of atrial fibrillation detection after cryptogenic stroke: 2-year findings from a multicentre study with Confirm Rx ICM

Crossref DOI link: https://doi.org/10.1136/openhrt-2025-003242

Published Online: 2025-06-12

Published Print: 2025-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Quartieri, Fabio https://orcid.org/0009-0003-3895-9858
Baek, Yong-Soo https://orcid.org/0000-0002-6086-0446
Park, Jong-Sung https://orcid.org/0000-0001-6996-2476
Kim, Tae-Hoon https://orcid.org/0000-0003-4200-3456
Honma, Kazunari

Morimoto, Masafumi

Kang, Ki-Woon https://orcid.org/0000-0002-1361-0022
Feng, Lin https://orcid.org/0009-0008-6846-3382
Lee, Kwangdeok https://orcid.org/0009-0006-9286-2565
Grammatico, Andrea https://orcid.org/0000-0001-6204-8745
Kaiser, Lukas https://orcid.org/0000-0001-7246-8954
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03505801 at ClinicalTrials.gov

Documents that mention this clinical trial

Continuing evaluation of atrial fibrillation detection after cryptogenic stroke: 2-year findings from a multicentre study with Confirm Rx ICM
https://doi.org/10.1136/openhrt-2025-003242
Funding

Funding for this research was provided by:

Abbott (NCT03505801)
License Information

License valid from 2025-06-12